Kim et al. [12] found that homozygous deletions of the CDKN2A (p16, p14) and the CDKN2B (p15) was a factor indicating poor prognosis in adult ALL patients, but it did not have a significant impact on prognosis in pediatric ALL patients. Here, CDKN2B is linked to acute lymphoblastic leukemia.